Literature DB >> 11086080

Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.

C Vilches1, C M Gardiner, P Parham.   

Abstract

Two variants of the novel KIR2DL5 gene (KIR2DL5.1 and.2) were identified in genomic DNA of a single donor. However, only the KIR2DL5.1 variant was transcribed in PBMC. In this study, analysis of seven additional donors reveals two new variants of the KIR2DL5 gene and indicates that transcription, or its lack, are consistently associated with particular variants of this gene. Comparison of the complete nucleotide sequences of the exons and introns of KIR2DL5.1 and KIR2DL5.2 reveals no structural abnormalities, but similar open reading frames for both variants. In contrast, the promoter region of KIR2DL5 shows a high degree of sequence polymorphism that is likely relevant for expression. Substitution within a putative binding site for the transcription factor acute myeloid leukemia gene 1 could determine the lack of expression for some KIR2DL5 variants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086080     DOI: 10.4049/jimmunol.165.11.6416

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing.

Authors:  Lihua Hou; Minghua Chen; Noriko Steiner; Kanthi Kariyawasam; Jennifer Ng; Carolyn K Hurley
Journal:  Methods Mol Biol       Date:  2012

2.  Promoter variants of KIR2DL5 add to diversity and may impact gene expression.

Authors:  Tiernan J Mulrooney; LiHua Hou; Noriko K Steiner; Minghua Chen; Ian Belle; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

Review 3.  Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters.

Authors:  Frank Cichocki; Jeffrey S Miller; Stephen K Anderson
Journal:  J Innate Immun       Date:  2011-03-11       Impact factor: 7.349

4.  KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).

Authors:  Ghislaine M Gallez-Hawkins; Xiuli Li; Anne E Franck; Ketevan Gendzekhadze; Ryotaro Nakamura; Stephen J Forman; David Senitzer; John A Zaia
Journal:  Hum Immunol       Date:  2012-08-30       Impact factor: 2.850

5.  Thirty allele-level haplotypes centered around KIR2DL5 define the diversity in an African American population.

Authors:  Lihua Hou; Minghua Chen; Bo Jiang; DongYing Wu; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Immunogenetics       Date:  2010-06-29       Impact factor: 2.846

6.  Conserved KIR allele-level haplotypes are altered by microvariation in individuals with European ancestry.

Authors:  L Hou; M Chen; J Ng; C K Hurley
Journal:  Genes Immun       Date:  2011-07-28       Impact factor: 2.676

7.  Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

Authors:  Steven G E Marsh; Peter Parham; Bo Dupont; Daniel E Geraghty; John Trowsdale; Derek Middleton; Carlos Vilches; Mary Carrington; Campbell Witt; Lisbeth A Guethlein; Heather Shilling; Christian A Garcia; Katharine C Hsu; Hester Wain
Journal:  Immunogenetics       Date:  2003-06-28       Impact factor: 2.846

8.  Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease.

Authors:  Yu-Lian Jiao; Chun-Yan Ma; Lai-Cheng Wang; Bin Cui; Jie Zhang; Li You; Zi-Jiang Chen; Jian-Feng Li; Yue-Ran Zhao
Journal:  J Clin Immunol       Date:  2008-02-23       Impact factor: 8.317

9.  Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation.

Authors:  Cheng-Ying Wu; Bin Zhang; Hansol Kim; Stephen K Anderson; Jeffrey S Miller; Frank Cichocki
Journal:  J Immunol       Date:  2020-08-05       Impact factor: 5.422

10.  Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.

Authors:  Noriko K Steiner; Sivanesan Dakshanamurthy; Christopher J VandenBussche; Carolyn K Hurley
Journal:  Immunogenetics       Date:  2008-08-06       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.